Omega Therapeutics Unveils New Epigenomic Controller Develop

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Thomas Mccauley , Jason Braco , Eva Stroynowski , Mahesh Karande , Omega Epigenomic , Linkedin , Twitter , American Society Of Gene Cell Therapy , Nitto Denko Corporation , Prnewswire Omega Therapeutics Inc , Nasdaq , Company Pioneering , Lifesci Communications , Second Development , Second Development Candidate Arising , Omega Epigenomic Controller , Investigational New Drug , Cell Therapy , Annual Meeting , Chief Scientific Officer , Chief Executive Officer , Flagship Pioneering , Omega Epigenomic Controllers , Precision Genomic Control , Private Securities Litigation Reform Act , Quarterly Report , Cancer Res Clin Oncol , Media Contact , Omega Therapeutics ,